Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Third-Party Viral Specific T Cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT.
Journal: Transplantation and cellular therapy
Published: April 19, 2026
Third-Party Viral Specific T cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT.
Journal: Transplantation and cellular therapy
Published: April 19, 2026
Emapalumab for Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Following CD19-Directed CAR-T in Two Patients With B-ALL: Clinical and Biomarker Correlates.
Journal: Pediatric blood & cancer
Published: January 22, 2026
Long-term Follow-up After Mixed Donor Myeloid Chimerism at 1 Year Post Transplantation for Sickle Cell Disease.
Journal: Transplantation and cellular therapy
Published: November 17, 2025
Abatacept for acute graft versus host disease prophylaxis in children with sickle cell disease patients undergoing HLA identical sibling hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation
Published: February 07, 2025
Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: December 08, 2023
COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report.
Journal: Journal of clinical immunology
Published: August 02, 2023
Age Impacts Risk of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Non-Severe Combined Immune Deficiency Inborn Errors of Immunity.
Journal: Transplantation and cellular therapy
Published: June 27, 2023
Viral specific T cell therapy in kidney transplant recipients - A single-center experience.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: June 07, 2023
Viral-specific T cells for Cytomegalovirus retinitis following hematopoietic stem cell transplantation: A success story.
Journal: Pediatric blood & cancer
Published: January 06, 2023
Last Updated: 09/26/2026